Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 8/20 | 0.47 |
| ▸ | PLA2G1B | P04054 | 3/20 | 0.47 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.47 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.46 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.41 |
| ▸ | PSMD14 | O00487 | 2/20 | 0.41 |
| ▸ | MMP2 | P08253 | 2/20 | 0.41 |
| ▸ | ATG4B | Q9Y4P1 | 2/20 | 0.41 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.41 |
| ▸ | RAD52 | P43351 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11612090 | 1.00 | GPR84 (0.47) | GPR84PLA2G1BPLA2G2AFFAR1FFAR4 | |
| SCHEMBL3533180 | 1.00 | GPR84 (0.47) | GPR84PLA2G1BPLA2G2AFFAR1FFAR4 | |
| SCHEMBL13354488 | 0.96 | GPR84 (0.44) | GPR84PLA2G1BPLA2G2AFFAR1FFAR4 | |
| SCHEMBL29234717 | 0.96 | GPR84 (0.44) | GPR84PLA2G1BPLA2G2AFFAR1FFAR4 | |
| SCHEMBL29234705 | 0.96 | GPR84 (0.44) | GPR84PLA2G1BPLA2G2AFFAR1FFAR4 | |
| SCHEMBL14980568 | 0.96 | GPR84 (0.47) | GPR84PLA2G1BPLA2G2AFFAR1FFAR4 | |
| SCHEMBL18789541 | 0.92 | GPR84 (0.44) | GPR84PLA2G1BPLA2G2AFFAR1FFAR4 | |
| SCHEMBL18789544 | 0.92 | GPR84 (0.44) | GPR84PLA2G1BPLA2G2AFFAR1FFAR4 | |
| SCHEMBL18789542 | 0.92 | GPR84 (0.44) | GPR84PLA2G1BPLA2G2AFFAR1FFAR4 | |
| SCHEMBL3540872 | 0.92 | GPR84 (0.47) | GPR84PLA2G1BPLA2G2AFFAR1FFAR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1812401-B1 | METHOD FOR PRODUCING PERYLENE-3,4-DICARBOXYLIC ACID IMIDES | BASF SE (DE) | 2015-06-24 | — | — | EP | disclosed |
| US-7799920-B2 | Method for producing perylene-3,4-dicarboxylic acid imides | BASF AKTIENGESELLSCHAFT (DE) | 2010-09-21 | — | — | US | disclosed |
| US-20080114170-A1 | Method For Producing Perylene-3,4-Dicarboxylic Acid Imides | BASF AKTIENGESELLSCHAFT (DE) | 2008-05-15 | — | — | US | disclosed |
| EP-1812401-A1 | METHOD FOR PRODUCING PERYLENE-3,4-DICARBOXYLIC ACID IMIDES | BASF AKTIENGESELLSCHAFT (DE) | 2007-08-01 | — | — | EP | disclosed |
| WO-2006050860-A1 | METHOD FOR PRODUCING PERYLENE-3,4-DICARBOXYLIC ACID IMIDES | BASF AKTIENGESELLSCHAFT (DE) | 2006-05-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080114170-A1 | Method For Producing Perylene-3,4-Dicarboxylic Acid Imides | CPNE4, IDH3A, RPL23A | GPR84 2855/4885PLA2G1B 3619/4885PLA2G2A 4105/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.